You are invited to attend a lunch satellite symposium held during the CAPhO Conference 2017 The Pharmacist and Immune Checkpoint Inhibition: Looking to the Future FRIDAY APRIL 21, 2017 12:15 PM – 1:45 PM Fairmont Banff Spring Hotel At a time when new treatment options are becoming available for the treatment of many cancers, the pharmacist is well placed and plays an instrumental part in not only recognizing and managing adverse events but also educating other members of the interdisciplinary team. This conference will demonstrate the value of collaboration with other healthcare professionals while sharing best practices of communication and management of immune-checkpoint inhibitors and immuno-related toxicities with patients and care givers. LEARNING OBJECTIVES • • • Summarize the latest practice-changing evidence affecting the treatment of patients with metastatic melanoma or lung cancer under immunotherapy (monotherapy or combination) Discuss the role of pharmacists within an interdisciplinary team in recognizing and managing immuno-related toxicities Review best practices in the effective management of immuno-related AEs EXPERT PANEL Scott Edwards, Pharm D, Msc (Oncology) Sean Hopkins, B.S.P. Clinical oncology pharmacy specialist, Dr. H. Bliss Murphy Cancer Center Assistant professor, School of Pharmacy and the Discipline of Oncology, Faculty of Medicine Memorial University of Newfoundland St. John's, Newfoundland Interim Operations Director, Simcoe Muskoka Regional Cancer Program Pharmacy Manager, Oncology Services and Research, Manager, Oncology Clinical Trials, Royal Victoria Regional Health Centre Barrie, Ontario This learning activity is sponsored by Merck Canada Inc.